Carcinogenesis, Vol. 21, No. 4, 641-646,
April 2000
© 2000 Oxford University Press
Carcinogenesis |
Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis
The University of Texas M.D. Anderson Cancer Center, Science Park–Department of Veterinary Sciences, Bastrop, TX 78602 and
1 The University of Texas M.D. Anderson Cancer Center, Science Park–Research Division, Smithville, TX 78957, USA
The development and initial characterization of five new inbred strains of SENCAR mice are described in this paper. Ten randomly selected pairs of outbred SENCAR mice were mated and offspring from each separately maintained parental line were sib mated at each successive generation to result in inbred strains. Due to poor reproductive performance only five of the original 10 lines were bred to homogeneity. Initial characterization of the five remaining lines (referred to as SL2/sprd, SL5/sprd, SL7/sprd, SL8/sprd and SLl0/sprd) at F12 for their responsiveness to a two-stage carcinogenesis protocol (10 nmol 7,12-dimethylbenz[a]anthracene and 0.25 µg 12-O-tetradecanoylphorbol-13 acetate) revealed three groups of responders in terms of the number of papillomas per mouse: SL2/sprd and SL8/sprd > SL7/sprd and SL10/sprd >> SL5/sprd. The papilloma responses in SL2/sprd and SL8/sprd were very similar to SENCAR B/Pt compared at the same doses. Papillomas induced on SL2/sprd had the highest propensity to progress to squamous cell carcinomas, similar to that observed in outbred SENCAR and SENCAR B/Pt mice. More detailed comparison of the responsiveness of SL2/sprd and SL5/sprd at Fl5 showed that these two inbred strains differed in their sensitivity to TPA-induced epidermal hyperplasia and that the dose of TPA required to produce a tumor response in SL5/sprd in comparison with that in SL2/sprd was 4–20 times higher. Overall, the availability of the different inbred SENCAR strains will greatly aid mechanistic studies of multistage skin carcinogenesis as well as studies to understand the underlying genetic basis of resistance to tumor promotion and progression in this model system.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. N. Bachman, G. M. Curtin, D. J. Doolittle, and J. I. Goodman Altered Methylation in Gene-Specific and GC-Rich Regions of DNA Is Progressive and Nonrandom during Promotion of Skin Tumorigenesis Toxicol. Sci., June 1, 2006; 91(2): 406 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Amornphimoltham, V. Sriuranpong, V. Patel, F. Benavides, C. J. Conti, J. Sauk, E. A. Sausville, A. A. Molinolo, and J. S. Gutkind Persistent Activation of the Akt Pathway in Head and Neck Squamous Cell Carcinoma: A Potential Target for UCN-01 Clin. Cancer Res., June 15, 2004; 10(12): 4029 - 4037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumoto, J. Jiang, K. Kiguchi, L. Ruffino, S. Carbajal, L. Beltran, D. K. Bol, M. P. Rosenberg, and J. DiGiovanni Targeted Expression of c-Src in Epidermal Basal Cells Leads to Enhanced Skin Tumor Promotion, Malignant Progression, and Metastasis Cancer Res., August 15, 2003; 63(16): 4819 - 4828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Angel, M. Caballero, and J. DiGiovanni Identification of Novel Genetic Loci Contributing to 12-O-Tetradecanoylphorbol-13-acetate Skin Tumor Promotion Susceptibility in DBA/2 and C57BL/6 Mice Cancer Res., June 1, 2003; 63(11): 2747 - 2751. [Abstract] [Full Text] [PDF]
|
|